+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Hemodialysis Catheters Market Size, Share & Trends Analysis Report By Material (Polyurethane, and Silicone), By Product (Cuffed Tunneled, Non-Cuffed Tunneled, and Non-Tunneled), By Tip Configuration, By End User, By Country and Growth Forecast, 2023 - 2030

  • PDF Icon

    Report

  • January 2024
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5935550
The North America Hemodialysis Catheters Market would witness market growth of 4.5% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 6,316.9 thousand units, showcasing a growth of 4.8% (2019-2022).

Hemodialysis is a blood filtration process for a person suffering from kidney failure. It is carried out by connecting a dialysis machine to the patient using a catheter as a connecting point. The catheter includes two types of lumens (flexible tubular passage) for the exchange of blood, which are colored red and blue for clear identification during the dialysis process. The red lumen (atrial lumen) draws blood from the patient and transfers it to the dialysis machine for filtration,a whereas the blue lumen (venous lumen) returns blood to the patient following filtration by the dialysis machine.

The primary driver for the adoption of these catheters is the increasing burden of chronic kidney diseases (CKD). CKD is a progressive condition that impairs kidney function over time, ultimately leading to end-stage renal disease (ESRD). As the prevalence of CKD rises, the demand for renal replacement therapies, including hemodialysis, also increases. These catheters become a critical component of the treatment process, especially when alternative vascular access options are limited.

As diabetes and hypertension are the main causes of CKD in Canada, their prevalence tends to be higher in the aging population. The presence of multiple chronic conditions increases the likelihood of individuals requiring hemodialysis for the management of ESRD in Canada. As the population in Canada continues to age, there is a higher incidence of individuals living with CKD, particularly in the elderly demographic. According to the Canadian Institute for Health Information, Canada's senior population of those 65 and older will expand by 68% over the next 20 years. It has more than tripled in size in the last 40 years. In 2017, it was around 6.2 million. It is anticipated to reach 10.4 million in 2037. This population in Canada is projected to increase by 2.1 times by 2037 from its size in 2017. Hence, the factors mentioned above will drive the regional market growth.

The US market dominated the North America Hemodialysis Catheters Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $202.7 Million by 2030. The Canada market is experiencing a CAGR of 5% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 5.5% during (2023 - 2030).

Based on Material, the market is segmented into Polyurethane, and Silicone. Based on Product, the market is segmented into Cuffed Tunneled, Non-Cuffed Tunneled, and Non-Tunneled. Based on Tip Configuration, the market is segmented into Step-Tip Catheters, Split-Tip Catheters, and Symmetric Catheters. Based on End User, the market is segmented into Hospitals, Clinics/Dialysis Centers, and Home Dialysis. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

  • Teleflex Incorporated
  • Medtronic Plc
  • AngioDynamics, Inc.
  • Bayer Ag
  • B.Braun Melsungen AG
  • Baxter International, Inc
  • NIPRO Corporation
  • Covalon Technologies Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.

Market Report Segmentation

By Material (Volume, Thousand Units, USD Billion, 2019-2030)
  • Polyurethane
  • Silicone
By Product (Volume, Thousand Units, USD Billion, 2019-2030)
  • Cuffed Tunneled
  • Non-Cuffed Tunneled
  • Non-Tunneled
By Tip Configuration (Volume, Thousand Units, USD Billion, 2019-2030)
  • Step-Tip Catheters
  • Split-Tip Catheters
  • Symmetric Catheters
By End User (Volume, Thousand Units, USD Billion, 2019-2030)
  • Hospitals
  • Clinics/Dialysis Centers
  • Home Dialysis
By Country (Volume, Thousand Units, USD Billion, 2019-2030)
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Hemodialysis Catheters Market, by Material
1.4.2 North America Hemodialysis Catheters Market, by Product
1.4.3 North America Hemodialysis Catheters Market, by Tip Configuration
1.4.4 North America Hemodialysis Catheters Market, by End User
1.4.5 North America Hemodialysis Catheters Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. North America Hemodialysis Catheters Market by Material
4.1 North America Polyurethane Market by Region
4.2 North America Silicone Market by Region
Chapter 5. North America Hemodialysis Catheters Market by Product
5.1 North America Cuffed Tunneled Market by Country
5.2 North America Non-Cuffed Tunneled Market by Country
5.3 North America Non-Tunneled Market by Country
Chapter 6. North America Hemodialysis Catheters Market by Tip Configuration
6.1 North America Step-Tip Catheters Market by Country
6.2 North America Split-Tip Catheters Market by Country
6.3 North America Symmetric Catheters Market by Country
Chapter 7. North America Hemodialysis Catheters Market by End User
7.1 North America Hospitals Market by Country
7.2 North America Clinics/Dialysis Centers Market by Country
7.3 North America Home Dialysis Market by Country
Chapter 8. North America Hemodialysis Catheters Market by Country
8.1 US Hemodialysis Catheters Market
8.1.1 US Hemodialysis Catheters Market by Material
8.1.2 US Hemodialysis Catheters Market by Product
8.1.3 US Hemodialysis Catheters Market by Tip Configuration
8.1.4 US Hemodialysis Catheters Market by End User
8.2 Canada Hemodialysis Catheters Market
8.2.1 Canada Hemodialysis Catheters Market by Material
8.2.2 Canada Hemodialysis Catheters Market by Product
8.2.3 Canada Hemodialysis Catheters Market by Tip Configuration
8.2.4 Canada Hemodialysis Catheters Market by End User
8.3 Mexico Hemodialysis Catheters Market
8.3.1 Mexico Hemodialysis Catheters Market by Material
8.3.2 Mexico Hemodialysis Catheters Market by Product
8.3.3 Mexico Hemodialysis Catheters Market by Tip Configuration
8.3.4 Mexico Hemodialysis Catheters Market by End User
8.4 Rest of North America Hemodialysis Catheters Market
8.4.1 Rest of North America Hemodialysis Catheters Market by Material
8.4.2 Rest of North America Hemodialysis Catheters Market by Product
8.4.3 Rest of North America Hemodialysis Catheters Market by Tip Configuration
8.4.4 Rest of North America Hemodialysis Catheters Market by End User
Chapter 9. Company Profiles
9.1 Teleflex Incorporated
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental Analysis
9.1.4 Research & Development Expense
9.1.5 SWOT Analysis
9.2 Medtronic PLC
9.2.1 Company overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expenses
9.2.5 SWOT Analysis
9.3 Baxter International, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 AngioDynamics, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 SWOT Analysis
9.5 B. Braun Melsungen AG
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 Nipro Corporation
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.7 Fresenius Medical Care AG & Co. KGaA
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 SWOT Analysis
9.8 Covalon Technologies Ltd.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Research & Development Expenses
9.9 DaVita Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 SWOT Analysis
9.10. Bayer AG
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis

Companies Mentioned

  • Teleflex Incorporated
  • Medtronic Plc
  • AngioDynamics, Inc.
  • Bayer Ag
  • B. Braun Melsungen AG
  • Baxter International, Inc
  • NIPRO Corporation
  • Covalon Technologies Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • DaVita Inc.

Methodology

Loading
LOADING...